Primary and Secondary Cardiovascular and Kidney Prevention With Canagliflozin: Insights From the CANVAS Program and CREDENCE Trial

Background This study evaluated the effects of canagliflozin in patients with type 2 diabetes with and without prevalent cardiovascular disease (secondary and primary prevention). Methods and Results This was a pooled participant‐level analysis of the CANVAS (Canagliflozin Cardiovascular Assessment...

Descrizione completa

Dettagli Bibliografici

Autori principali:	Abhinav Sharma, Amir Razaghizad, Abdulaziz Joury, Adeera Levin, Harpreet S. Bajaj, G. B. John Mancini, Norman C. Wong, April Slee, Fernando G. Ang, Wally Rapattoni, Brendon L. Neuen, Clare Arnott, Vlado Perkovic, Kenneth W. Mahaffey
Natura:	Artigo
Lingua:	Inglês
Pubblicazione:	Wiley 2024-02-01
Serie:	Journal of the American Heart Association: Cardiovascular and Cerebrovascular Disease
Soggetti:	canagliflozin primary and secondary prevention type 2 diabetes
Accesso online:	https://www.ahajournals.org/doi/10.1161/JAHA.123.031586
Tags:	Aggiungi Tag Nessun Tag, puoi essere il primo ad aggiungerne!!